Navigation Links
MDS Reports Third Quarter 2007 Results
Date:9/6/2007

ncertainties and potential events. We do not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by us or on our behalf.

Use of Non-GAAP Measures

In addition to measures based on generally accepted accounting principles (GAAP) in this MD&A, we use terms such as adjusted operating income; adjusted earnings before interest, taxes, depreciation and amortization (EBITDA); EBITDA margin; adjusted EPS; operating working capital; and backlog. These terms are not defined by GAAP and our use of such terms or measurement of such items may vary from that of other companies. In addition, measurement of both reported and organic growth is not defined by GAAP and our use of these terms or measurement of these items may vary from that of other companies. Where relevant, and particularly for earnings-based measures, we provide tables in this document that reconcile the non-GAAP measures used to amounts reported on the face of the consolidated financial statements.

Our executive management team assesses the performance of our businesses based on a review of results comprising these non-GAAP measures and GAAP measures. We also report on our performance to the Company's Board of Directors based on these GAAP and non-GAAP measures. In addition, adjusted EBITDA and operating working capital are the primary metrics for our annual incentive compensation plan for senior management. We provide this non-GAAP detail so that readers have a better understanding of the significant events and transactions that have had an impact on our results and can view our results through the eyes of management.

We also discuss the results of our operations, isolating variances that relate to changes in exchange rates and to acquisitions and divestitures. We use the term "organic" to describe the results presented in this way. To isolate the effect of currency movements, we eliminate the impact of foreign currency hedging activ
'/>"/>

SOURCE MDS Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
International Day Of Action For Women's Health - 2007
...on has adopted yet another spiritual ploy to keep ...as to report to Los Angeles' Century Regional Dete...irt featuring a picture of the Virgin Mary. In th...as been spotted holding a Bible, visiting a Buddhi...
...aking following revelations that a common preserva...epsi Max has the ability to switch off vital part...r when parts of DNA are disabled, as it were, it c... liver and degenerative diseases such as Parkinson...
...are more likely to try kicking the habit and are m...niversity of Rochester . Rochester researcher Dr.... at the University of Rochester School of Medicine...ings at a Toronto conference this month that demon...
Other Medicine News:Health News:International Day Of Action For Women's Health - 2007 2Health News:International Day Of Action For Women's Health - 2007 3Health News:International Day Of Action For Women's Health - 2007 4Health News:Soft Drink Additive Could Cause Cell Damage 2Health News:Soft Drink Additive Could Cause Cell Damage 3Health News:Choice is a Key Element in Success for Smokers Who Want to Quit 2
(Date:8/25/2008)...lls Found in Menstrual Blood May Offer Long-Lastin...ed Women, OLDSMAR, Fla., Aug. 25 /- ...ould agree that there never seems to be enough,of ... doing something just,for herself usually pales in...s reality has led many women in need of quality ti...
(Date:8/25/2008)...s., Aug. 25 /- Joseph F. Finn, Jr.,C..., Inc. ("Spherics") for,the benefit of creditors, ...al property will be sold at a sealed bid auction o...se formulation of Levodopa-Carbidopa that,is the c...ease, with global,sales estimated at approximately...
(Date:8/25/2008)...ug. 25 /- Anthera Pharmaceuticals,Inc...loping,anti-inflammatory drugs, today announced th... coronary events with Near-term Cardiovascular,Inf...examine the impact of,varespladib when administere... Syndrome (ACS) event., The FRANCIS trial is desi...
(Date:8/22/2008)... in Trial Sponsored by Medical Research Council, ...- Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) a...tocol MDP 301, a Phase III clinical trial of PRO 2...or the prevention of HIV and other,sexually transm...ited,Kingdom,s Medical Research Council (MRC) and ...
Breaking Medicine Technology:Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index 842 1Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index 842 2Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index 842 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference 28ECCO 29 395 1Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference 28ECCO 29 395 2Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference 28ECCO 29 395 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference 28ECCO 29 395 4Heart Attack Survivors Benefit From Rehab 2063 1Heart Attack Survivors Benefit From Rehab 2063 2Mixing large doses of both acetaminophen painkiller and caffeine may increase risk of liver damage 568 1Mixing large doses of both acetaminophen painkiller and caffeine may increase risk of liver damage 568 2
... Researchers at,Molecular Insight Pharmaceuticals ...ta on MIP-1072, a radiolabeled, small molecule,mol...iagnosis and,staging of prostate cancer at the 54t...e (SNM) in Washington, D.C. MIP-1072 is,one of two...sis,that Molecular Insight plans to advance into e...
...Corporation,(NASDAQ: CYTO) today reported results ...(samarium Sm-153 lexidronam injection),can be safe...e also,receiving the chemotherapy docetaxel (Taxot...t further evaluation of the combination,regimen fo...ogram.,The results were presented and/or published...
Other Medicine Technology:Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 4New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 2New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 3New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 4New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 5New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 6New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 7
This fume hood features a one-piece shell molded of polyethylene with a clear acrylic panel that slides on inside tracks. It can be set in an open, closed or intermediate position.
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available.
...e offers the ultimate in versatility combined with...afety. ,Designed to meet the needs of the routin...e more demanding requirements of the specialised u...ories will guarantee that it becomes the first cho...
The Starter Package is a solid solution for setting up your laboratory. The package includes the Vibratome Plus, standard accessory kit, additional mounting blocks, v-block adapter, specimen mounts w
Medicine Products: